Information Journal Paper
APA:
Copy. (2019). HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b. MEDICINE (BALTIMORE), 98(10), 0-0. SID. https://sid.ir/paper/784140/en
Vancouver:
Copy. HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b. MEDICINE (BALTIMORE)[Internet]. 2019;98(10):0-0. Available from: https://sid.ir/paper/784140/en
IEEE:
Copy, “HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b,” MEDICINE (BALTIMORE), vol. 98, no. 10, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/784140/en